CEPHADOL Side Effects

5393335-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Pressure Decreased, Blood Urea Increased, C-reactive Protein Increased, Dehydration
on Jul 19, 2007 Female patient from JAPAN , 66 years of age, weighting 119.0 lb, was diagnosed with dizziness (What is dizziness?), hyperuricaemia, nausea (What is nausea?), chronic myeloid leukaemia and was treated with Cephadol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased, blood pressure decreased, blood urea increased, c-reactive protein increased, dehydration. Cephadol dosage: 3 Df/day. During the same period patient was treated with URALYT (6 Df/day) (View Uralyt Review and Uralyt Label ), ALLOPURINOL (300 Mg/day) (View Allopurinol Review and Allopurinol Label ), NOVAMIN (15 Mg/day) (View Novamin Review and Novamin Label ), TICLOPIDINE HCL (200 Mg/day) (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), MERISLON (18 Mg/day) (View Merislon Review and Merislon Label ), GLEEVEC (400 Mg/day) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5387285-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Pressure Decreased, Blood Urea Increased, C-reactive Protein Increased, Dehydration
Patient was taking Cephadol (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased, blood pressure decreased, blood urea increased, c-reactive protein increased, dehydration on Jul 11, 2007 from JAPAN Additional patient health information: Female patient , 66 years of age, weighting 119.0 lb, was diagnosed with dizziness (What is dizziness?), hyperuricaemia, nausea (What is nausea?), chronic myeloid leukaemia and. Cephadol dosage: 3 Df/day. During the same period patient was treated with URALYT (6 Df/day) (View Uralyt Review and Uralyt Label ), ALLOPURINOL (300 Mg/day) (View Allopurinol Review and Allopurinol Label ), NOVAMIN (15 Mg/day) (View Novamin Review and Novamin Label ), TICLOPIDINE HCL (200 Mg/day) (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), MERISLON (18 Mg/day) (View Merislon Review and Merislon Label ), GLEEVEC (400 Mg/day) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5285106-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Pressure Decreased, Blood Urea Increased, C-reactive Protein Increased, Dehydration
Adverse event was reported on Mar 28, 2007 by a Female patient taking Cephadol (View Usage) (Dosage: 3 Df/day) was diagnosed with dizziness (What is dizziness?), hyperuricaemia, nausea (What is nausea?), chronic myeloid leukaemia and. Location: JAPAN , 66 years of age, weighting 119.0 lb, After Cephadol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased, blood pressure decreased, blood urea increased, c-reactive protein increased, dehydration. During the same period patient was treated with URALYT (6 Df/day) (View Uralyt Review and Uralyt Label ), ALLOPURINOL (300 Mg/day) (View Allopurinol Review and Allopurinol Label ), NOVAMIN (15 Mg/day) (View Novamin Review and Novamin Label ), TICLOPIDINE HCL (200 Mg/day) (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), MERISLON (18 Mg/day) (View Merislon Review and Merislon Label ), GLEEVEC (400 Mg/day) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5153933-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Pressure Decreased, Blood Urea Increased, C-reactive Protein Increased, Dehydration
on Oct 11, 2006 Female patient from JAPAN , 66 years of age, was diagnosed with dizziness (What is dizziness?), hyperuricaemia, nausea (What is nausea?), chronic myeloid leukaemia and was treated with Cephadol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased, blood pressure decreased, blood urea increased, c-reactive protein increased, dehydration. Cephadol dosage: 3 Df/day. During the same period patient was treated with URALYT (6 Df/day) (View Uralyt Review and Uralyt Label ), ALLOPURINOL (300 Mg/day) (View Allopurinol Review and Allopurinol Label ), NOVAMIN (15 Mg/day) (View Novamin Review and Novamin Label ), PANALDINE (200 Mg/day) (View Panaldine Review and Panaldine Label ), MERISLON (18 Mg/day) (View Merislon Review and Merislon Label ), GLEEVEC (400 Mg/day) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.


4811335-2 | Chest Pain, Coronary Arterial Stent Insertion, Electrocardiogram St Segment Depression, Myocardial Infarction
on Aug 05, 2005 Male patient from JAPAN , 69 years of age, weighting 160.9 lb, was diagnosed with dizziness (What is dizziness?), psychosomatic disease, hypertension, cerebral infarction, hypercholesterolaemia and was treated with Cephadol (View Usage). Patient had the following side effects: chest pain (What is chest pain?), coronary arterial stent insertion, electrocardiogram st segment depression, myocardial infarction. Cephadol dosage: . During the same period patient was treated with SOLANAX (View Solanax Review and Solanax Label ), BLOPRESS (View Blopress Review and Blopress Label ), MUNOBAL (View Munobal Review and Munobal Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOCHOL (20 Mg, Qd) (View Lochol Review and Lochol Label ). Patient was hospitalized.

4743694-3 | Coronary Arterial Stent Insertion, Myocardial Infarction
Patient was taking Cephadol (View Usage). After Cephadol was administered, patient had the following side effects: coronary arterial stent insertion, myocardial infarction on Aug 05, 2005 from JAPAN Additional patient health information: Male patient , 69 years of age, weighting 160.9 lb, was diagnosed with dizziness (What is dizziness?), psychosomatic disease, hypertension, cerebral infarction, hypercholesterolaemia and. Cephadol dosage: . During the same period patient was treated with SOLANAX (View Solanax Review and Solanax Label ), BLOPRESS (View Blopress Review and Blopress Label ), MUNOBAL (View Munobal Review and Munobal Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOCHOL (20 Mg, Qd) (View Lochol Review and Lochol Label ). Patient was hospitalized.